Clinical Trial Update: Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial assessing mesenchymal stem cell therapy for dry eye disease in patients with Sjögren's syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconjunctivitis Sicca in Sjögren Syndrome

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Keratoconjunctivitis Sicca, in Sjogren's Syndrome | Phase 2 | Status: COMPLETED